Head-to-head · Cost-Efficiency Index
Cabana vs Actin
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Cabana
Shoppers who want a lifestyle-branded concierge wellness experience bundling GLP-1 with other treatments.
Visit CabanaActin
Cost-first shoppers who want not clearly established from public content -- insufficient disclosed detail to recommend a fit.
Visit ActinThe verdict
Cabana takes it, leading the Cost-Efficiency Index 40 to 39. Cabana is a concierge wellness brand offering compounded GLP-1 semaglutide and tirzepatide (injections and a semaglutide tablet) alongside NAD+ energy products, advertised from $249/month. Actin still earns a C — Cost-first shoppers who want not clearly established from public content -- insufficient disclosed detail to recommend a fit.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Cabana.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Cabana | Actin |
|---|---|---|
| Cost-Efficiency Index | 40/100 | 39/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #525 | #530 |
Cabana
40/100Where the value is
- Offers a semaglutide tablet option in addition to injectables
- Single, findable headline price ($249/mo starting) visible without an account
- Explicit disclaimer distinguishing FDA-approved vs. compounded (non-FDA-approved) medications
The tradeoffs
- Pricing is not broken out by specific drug or dose -- unclear what a semaglutide vs. tirzepatide patient actually pays
- 'Starting At' framing with no clarification of whether $249 is promotional or standard
Actin
39/100Where the value is
- Multi-condition platform (weight, hormones, sexual wellness, hair) under one account
- States it uses 'state-licensed compounding pharmacies' with third-party potency/sterility testing
- Clean, modern telehealth positioning
The tradeoffs
- No semaglutide or tirzepatide pricing published anywhere accessible
- No named compounding pharmacy partner despite claiming to use one
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.